Back to search

Article

Anti-HBV Therapy in Hepatocellular Carcinoma May Affect the Symptoms of SARS-CoV-2 Infection

2023-05-22

Abstract excerpt

Background: Anti-HBV therapy is an important therapy for improving the prognosis of patients with HCC, but the effect of long term Entecavir (ETV) treatment on SARS-CoV-2 infection is not clear.<br><br>Methods: A total of 275 hepatocellular carcinoma (HCC) patients were included in the retrospective review. In the case of SARS-CoV-2 infection, the clinical symptom grading criteria were adopted from the ten edition...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
794afb63-5c5e-5c66-9eab-d655191c33cf
DOI
10.2139/ssrn.4453488
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Anti-HBV Therapy in Hepatocellular Carcinoma May Affect the Symptoms of SARS-CoV-2 InfectionDOI 10.2139/ssrn.4453488
Select a neighboring publication to make it the new centre.